8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)
Published . Updated .
Filed: 2026-10-07 AccNo: 0001213900-26-107442 Size: 233 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- CVKD Cadrenal Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-07 AccNo: 0001213900-26-107442 Size: 233 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Cadrenal Therapeutics (CVKD) since this story, compared with the market
Since the first closing price after “8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer),” Cadrenal Therapeutics (CVKD) is +14.44%. The S&P 500 fund (SPY) is -0.94% over the same days, a +15.38% difference versus the market.
Who gains and who loses around Cadrenal Therapeutics (CVKD)
Companies tied to this story
- CVKD Cadrenal Therapeutics
For “8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer),” Cadrenal Therapeutics (CVKD) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CVKD
How “8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)” reaches Cadrenal Therapeutics (CVKD)
“8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)” (7 Oct 2026) reaches Cadrenal Therapeutics (CVKD) through this story.
For Cadrenal Therapeutics (CVKD), the reason on file says SEC 8-K filing -> direct issuer disclosure -> CVKD
Price levels for Cadrenal Therapeutics (CVKD)
CVKD traded between 0.88 and 2.27 across 20 sessions. The latest close on file is 1.05.
How solid “8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)” looks
14 out of 100
“8-K - Cadrenal Therapeutics, Inc. (0001937993) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.